Expressive Writing Program Among Young Adults With Blood Cancer

Part of paid clinical trials in Washington D.C., District of Columbia.

Sponsor
Blood Cancer United
Study ID
NCT07413991
Status
Recruiting
Apply to this trial

Conditions

  • Hematologic Malignancy

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Expressive Writing Workshop — BEHAVIORAL
    Group 1 will start the workshop the following week. Group 2 will wait 4 weeks before starting the workshop. There is an equal chance of being placed group 1 or group 2. You cannot choose your study group. The workshop is the same for both groups.

Study Details

The goal of this study is to learn more about an expressive writing workshop among people with blood cancer. The main question it aims to answer is whether and how an expressive writing workshop can impact mental wellness. Participants will * Take part in an online expressive writing workshop for four weeks * Take three surveys at different times over 12 weeks Researchers will compare changes in mental wellness reported by the participants of the workshop to those who will wait four weeks to start the workshop. After four weeks, the participants who are waiting will start their workshop.

Key Dates

Start date
Feb 1, 2026
Status verified
Feb 2026
Primary completion
Sep 30, 2026
Completion
Sep 30, 2026

Study Design

Enrollment
100 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: Group 1
    Primary Intervention Group
  • Placebo Comparator: Group 2
    Wait List Control Group

Primary Outcome Measure

Mental Wellbeing [ Time Frame: Baseline, 4, and 8 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Blood Cancer UnitedWashington D.C.District of Columbia20005
Research Coordinator
[email protected]
914-821-8862
D
+1 914 821 8305
Elisa S Weiss, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Washington D.C., DC

By research site
Blood Cancer United· Washington D.C., DC

Related Studies